Olanzapine
Product Images NDC 67296-1668

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67296-1668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

This text contains the National Drug Code (NDC) for Olanzapine Tablets, USP. It also indicates that pharmacists should dispense a Medication Guide to each patient and keep the drugs out of reach of children. Additionally, it mentions that the medication should be stored at 25 °C and the dosage strength is not available.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

This is a description for Olanzapine Tablets, USP. It includes instructions for pharmacists to dispense the accompanying Medication Guide to each patient and emphasizes keeping the medication out of the reach of children. The text also includes references to NDC code, lot number, expiration date, and other identification details.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

This is not readable.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

This text contains information about Olanzapine Tablets, USP with a recommended dosage of 75 mg. It also instructs the pharmacist to dispense a Medication Guide to each patient and to keep the drugs out of reach. The manufacturer is mentioned as Qi PrarmacoubalCo Ltd.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

Each blister contains 7.5 mg of the drug, USP. The NDC number 69543-382-30 corresponds to Olanzapine tablets, USP. Pharmacists are advised to provide the Medication Guide to every patient. It is essential to keep all medications out of the reach of children.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

This text provides information about a medication called Olanzapine Tablets, USP, where each tablet contains 10mg of arzapi. It also includes an NDC code for identification and a note for pharmacists to dispense a Medication Guide to each patient. The text emphasizes keeping the medication and all drugs out of reach, indicating it may be important to store medications safely.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

Each tablet contains 15 mg of Olanzapine, USP. The recommended dosage is 520 mg daily with food. This medication is supplied in a container with 30 tablets under NDC 69543-384-30. It is important for pharmacists to provide the accompanying Medication Guide to each patient. Remember to keep this drug and all medications out of reach of children.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

This text provides information about Olanzapine Tablets, USP with National Drug Code (NDC) 69543-384-30. It instructs pharmacists to dispense the accompanying Medication Guide to each patient and reminds to keep the drug out of reach. The text also mentions to protect the medication from light and moisture. Additionally, it includes a reference to AP VIRTUS and some unclear characters.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

This is a description for medication packaging. The text includes instructions to keep the package tightly closed, store in a controlled room, a National Drug Code (NDC) number, name of the medication (Olanzapine Tablets, USP), guidance for pharmacists to dispense a Medication Guide to each patient, a reminder to keep all drugs out of reach of children, prescription label indication (Rx Only), and the brand name VIRTUS®.*

FDA Label Image

Image Description (Olanzapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.